Actively Recruiting
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
Led by Englewood Hospital and Medical Center · Updated on 2025-07-23
125
Participants Needed
1
Research Sites
684 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.
CONDITIONS
Official Title
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient plans to have partial liver resection for primary liver pathology or metastatic disease
- Patient is able to comprehend and willing to sign the written consent form
You will not qualify if you...
- Patients under 18 years
- Patients identified as members of a vulnerable population, except women of child bearing potential with negative pregnancy test
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Englewood Hospital
Englewood, New Jersey, United States, 07631
Actively Recruiting
Research Team
J
Jamie Ketas
CONTACT
R
Raquel Molina
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here